$TXG

$72.96 +$1.41 (1.97%) Close

$TXG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$TXG Management Team

Dr. Benjamin Hindson

President

Co-Founder

Chief Scientific Officer

Director

Age 50

Compensation $4.270M USD

Sex Male

Mr. Serge Saxonov

Chief Executive Officer

Co-Founder

Director

Age 48

Compensation $7.929M USD

Sex Male

Mr. Adam Taich

Chief Financial Officer

Age 50

Compensation $3.296M USD

Sex Male

Mr. Eric Whitaker

Chief Legal Officer

Age 58

Compensation $6.996M USD

Sex Male

Dr. Randy Wu

General Counsel

Company Secretary

Age -

Compensation -

Sex Male

Dr. John Stuelpnagel

Independent Chairman of the Board

Age 67

Compensation $318.3K USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Benjamin Hindson President Co-Founder Chief Scientific Officer Director	50	$4.270M USD	Male
Mr. Serge Saxonov Chief Executive Officer Co-Founder Director	48	$7.929M USD	Male
Mr. Adam Taich Chief Financial Officer	50	$3.296M USD	Male
Mr. Eric Whitaker Chief Legal Officer	58	$6.996M USD	Male
Dr. Randy Wu General Counsel Company Secretary	-	-	Male
Dr. John Stuelpnagel Independent Chairman of the Board	67	$318.3K USD	Male

Board of Directors

From the proxy statement filed Apr 24, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy; 1 not stated

Average tenure

8.1 years

from year joined

CEO also chairs the board

John R. Stuelpnagel

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Serge Saxonov CEO	49	2012 14 years	Not independent	None stated	None stated	Paid as CEO
Benjamin J. Hindson Executive officer	51	2012 14 years	Not stated	None stated	None stated	Not stated
John R. Stuelpnagel Board chair	68	2013 13 years	Independent	audit committee compensation committee mergers and acquisitions committee	None stated	$283,413
Alan Mateo	64	2024 2 years	Independent	audit committee compensation committee nominating and corporate governance committee	None stated	$208,273
Kimberly J. Popovits	67	2020 6 years	Independent	audit committee compensation committee	Kiniksa Pharmaceuticals, Ltd., Exact Sciences	$216,323
Sarah Teichmann	50	2024 2 years	Independent	None stated	None stated	$198,323
Sri Kosaraju	48	2019 7 years	Independent	mergers and acquisitions committee	None stated	$223,323
Shehnaaz Suliman	54	2019 7 years	Independent	mergers and acquisitions committee nominating and corporate governance committee	Ultragenyx Pharmaceutical Inc.	$210,994

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$TXG Management Team

Dr. Benjamin Hindson

Mr. Serge Saxonov

Mr. Adam Taich

Mr. Eric Whitaker

Dr. Randy Wu

Dr. John Stuelpnagel

Board of Directors

Related-party transactions

No related-party transactions disclosed